Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Adenocarcinoma × Liquid Biopsy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Neoplastic Cells, Circulating 4 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Neuroendocrine Tumors 2 Lung Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Salivary Gland Neoplasms 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Mouth Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hematopoietic and Lymphoid System Neoplasm 1 Head and Neck Neoplasms 1 Glioma 1 Disease 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colonic Neoplasms 1 Carcinoma, Lobular 1

Interventions

Oxaliplatin 42 Gemcitabine 41 Fluorouracil 37 Capecitabine 29 pembrolizumab 28 Leucovorin 26 Docetaxel 25 Cisplatin 24 Paclitaxel 21 Carboplatin 18 Bevacizumab 17 Irinotecan 16 130-nm albumin-bound paclitaxel 16 Pemetrexed 15 Radiotherapy 13 Albumin-Bound Paclitaxel 13 Nivolumab 12 Cyclophosphamide 10 Ramucirumab 9 Trastuzumab 7 Radiosurgery 7 cemiplimab 6 Taxes 6 Erlotinib Hydrochloride 6 Drug Therapy 6 zolbetuximab 5 trastuzumab deruxtecan 5 durvalumab 5 Sorafenib 5 S 1 (combination) 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06090214 2023-10-19

BLADE

University Hospital, Montpellier

Phase NA Unknown

Adenocarcinoma, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡